Chang‐Woo Lee

5.6k total citations
164 papers, 3.5k citations indexed

About

Chang‐Woo Lee is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Chang‐Woo Lee has authored 164 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 37 papers in Cell Biology and 33 papers in Oncology. Recurrent topics in Chang‐Woo Lee's work include Microtubule and mitosis dynamics (30 papers), Ubiquitin and proteasome pathways (21 papers) and Cancer-related Molecular Pathways (21 papers). Chang‐Woo Lee is often cited by papers focused on Microtubule and mitosis dynamics (30 papers), Ubiquitin and proteasome pathways (21 papers) and Cancer-related Molecular Pathways (21 papers). Chang‐Woo Lee collaborates with scholars based in South Korea, United States and Ethiopia. Chang‐Woo Lee's co-authors include Nicholas B. La Thangue, Noriko Shikama, Kwan‐Hyuck Baek, Geun‐Hyoung Ha, Marija Krstic–Demonacos, Hyunjin Shin, Troels S. Sørensen, Chang‐Min Kim, Jonathan J. Lyon and Frank McKeon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Chang‐Woo Lee

160 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang‐Woo Lee South Korea 33 2.2k 977 615 461 369 164 3.5k
John T. Seykora United States 35 2.2k 1.0× 1.3k 1.4× 908 1.5× 708 1.5× 538 1.5× 108 4.8k
Todd W. Ridky United States 26 1.8k 0.8× 926 0.9× 464 0.8× 306 0.7× 404 1.1× 44 3.2k
Panomwat Amornphimoltham United States 32 2.1k 1.0× 1.1k 1.1× 442 0.7× 616 1.3× 608 1.6× 55 3.7k
Annapoorni Rangarajan India 34 2.6k 1.2× 1.6k 1.6× 449 0.7× 330 0.7× 866 2.3× 74 4.4k
Michael Cammer United States 34 1.8k 0.8× 1.1k 1.1× 1.1k 1.8× 1.3k 2.7× 342 0.9× 71 4.3k
Robert E. Hollingsworth United States 32 2.0k 0.9× 1.4k 1.5× 411 0.7× 942 2.0× 392 1.1× 66 3.7k
Qiao Zhou China 28 2.7k 1.2× 541 0.6× 362 0.6× 621 1.3× 839 2.3× 98 4.1k
Semi Kim South Korea 30 1.9k 0.8× 559 0.6× 317 0.5× 432 0.9× 593 1.6× 108 3.5k
Christopher R. Shea United States 39 1.3k 0.6× 1.6k 1.6× 616 1.0× 499 1.1× 332 0.9× 157 4.4k
Yasushi Hanakawa Japan 37 1.6k 0.7× 951 1.0× 493 0.8× 1.2k 2.5× 357 1.0× 76 4.4k

Countries citing papers authored by Chang‐Woo Lee

Since Specialization
Citations

This map shows the geographic impact of Chang‐Woo Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Woo Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Woo Lee more than expected).

Fields of papers citing papers by Chang‐Woo Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Woo Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Woo Lee. The network helps show where Chang‐Woo Lee may publish in the future.

Co-authorship network of co-authors of Chang‐Woo Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Woo Lee. A scholar is included among the top collaborators of Chang‐Woo Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Woo Lee. Chang‐Woo Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Park, Junhee, et al.. (2025). The ubiquitin ligase Pellino1 targets STAT3 to regulate macrophage-mediated inflammation and tumor development. Nature Communications. 16(1). 1256–1256. 6 indexed citations
3.
Lee, Chang‐Woo, Zhigang Yu, Calvin Kuo, et al.. (2025). Peripherally administered androgen receptor–targeted antisense oligonucleotide rescues spinal pathology in a murine SBMA model. Journal of Clinical Investigation. 135(21).
4.
Gariani, Karim, Joanna Gariani, Junguee Lee, et al.. (2024). Loss of hepatic Sirt7 accelerates diethylnitrosamine (DEN)-induced formation of hepatocellular carcinoma by impairing DNA damage repair. BMB Reports. 57(2). 98–103. 2 indexed citations
5.
Tejwani, Leon, Youngseob Jung, Hiroshi Kokubu, et al.. (2023). Reduction of nemo-like kinase increases lysosome biogenesis and ameliorates TDP-43–related neurodegeneration. Journal of Clinical Investigation. 133(16). 9 indexed citations
6.
7.
Lee, Janet, Jeong‐Hwa Baek, Kyu‐Sil Choi, et al.. (2013). Cyclin-dependent kinase 4 signaling acts as a molecular switch between syngenic differentiation and neural transdifferentiation in human mesenchymal stem cells. Cell Cycle. 12(3). 442–451. 8 indexed citations
8.
Han, Yu, Jae Ho Lee, Ga‐Young Park, et al.. (2012). A possible usage of a CDK4 inhibitor for breast cancer stem cell-targeted therapy. Biochemical and Biophysical Research Communications. 430(4). 1329–1333. 20 indexed citations
9.
Lee, Chang‐Woo, et al.. (2011). Effects of Needle-Embedding Therapy on Sequelae of Peripheral Facial Palsy : A Case Series. Journal of Acupuncture Research. 28(4). 93–103. 22 indexed citations
10.
Jeong, Manbok, et al.. (2010). A Case of Feline Proliferative Eosinophilic Keratitis Treated by Topical Cyclosporine and Corticosteroids. Journal of Veterinary Clinics. 27(6). 751–754. 1 indexed citations
11.
Kim, Mirang, Jeonghwan Kim, Hay-Ran Jang, et al.. (2008). LRRC3B , Encoding a Leucine-Rich Repeat-Containing Protein, Is a Putative Tumor Suppressor Gene in Gastric Cancer. Cancer Research. 68(17). 7147–7155. 46 indexed citations
12.
Kim, Hyun Soo, Geun‐Hyoung Ha, Hye-Young Park, et al.. (2008). Functional Interaction between BubR1 and Securin in an Anaphase-Promoting Complex/CyclosomeCdc20–Independent Manner. Cancer Research. 69(1). 27–36. 13 indexed citations
13.
Ha, Geun‐Hyoung, Kwan‐Hyuck Baek, Hyun Soo Kim, et al.. (2007). p53 Activation in Response to Mitotic Spindle Damage Requires Signaling via BubR1-Mediated Phosphorylation. Cancer Research. 67(15). 7155–7164. 42 indexed citations
14.
Park, Hye-Young, et al.. (2007). Differential promoter methylation may be a key molecular mechanism in regulating BubR1 expression in cancer cells. Experimental & Molecular Medicine. 39(2). 195–204. 40 indexed citations
15.
Park, Soowon, et al.. (2005). Seroprevalence of FeLV and FIV Infections in Domestic Cats in Korea. 22(1). 1–5. 1 indexed citations
16.
Lee, Chang‐Woo, et al.. (2003). Neonatal Lupus Erythematosus. Linchuang pifuke zazhi. 41(8). 1108–1110. 2 indexed citations
17.
Song, Yong Sang, et al.. (2002). Interaction and activation of luteinizing hormone receptor. Indian Journal of Experimental Biology. 40(4). 424–433. 1 indexed citations
18.
Lee, Jong Bok, et al.. (2002). Chronic Lymphocytic Leukemia in a Dog. 한국임상수의학회지. 19(4). 429–432. 4 indexed citations
19.
Pal, Mrinal, Saurabh Dahiya, & Chang‐Woo Lee. (1990). Family Pets as a Source of Microspoum canis Infection. 한국임상수의학회지. 7(2). 521–525. 1 indexed citations
20.
Lee, Chang‐Woo, et al.. (1981). Pemphigus Vulgaris Developed During Pregnancy.. Linchuang pifuke zazhi. 19(1). 99–103.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John T. Seykora Breakdown of academic impact, for papers by Todd W. Ridky Breakdown of academic impact, for papers by Panomwat Amornphimoltham Breakdown of academic impact, for papers by Annapoorni Rangarajan Breakdown of academic impact, for papers by Michael Cammer Breakdown of academic impact, for papers by Robert E. Hollingsworth Breakdown of academic impact, for papers by Qiao Zhou Breakdown of academic impact, for papers by Semi Kim Breakdown of academic impact, for papers by Christopher R. Shea Breakdown of academic impact, for papers by Yasushi Hanakawa
Rankless by CCL
2026